ODDB.org: Open Drug Database | Médicaments | Information professionnelle

Home - Ipro sur Colpro®

Information professionnelle sur Colpro®:

AHP (Schweiz) AG

Information professionnelle complète	DDD	imprimé
Forme gal./Grpe.th.	Composit.	Propriétés	Pharm.cinét.	Indic./emploi	Posolog./mode d'empl.	Précautions	Effets indésir.
Interact.	Surdosage	Remarques	Num. Swissmedic	Mise à jour

G03DB03 - Medrogestone

ATC-DDD Version 2016. Source: WHO

G - Genito Urinary System and Sex Hormones

G03 - Sex Hormones and Modulators Of The Genital System

Other hormones, see H - Systemic hormonal preparations, excl. sex hormones and insulins.
Sex hormones used only in the treatment of neoplastic diseases (often selected strengths) are classified in L - Antineoplastic and immunomodulating agents.

The DDDs of many of the hormone preparations may vary considerably with the route of administration due to substantial differences in bioavailability. The DDDs of depot preparations are calculated as the dose divided by the dosing interval.

G03D - Progestogens

This group comprises progestogens and combinations, except combinations with
- androgens, see G03E
- estrogens, see G03F
Hormonal contraceptives, see G03A
IUDs (intrauterine dervices) with progestogens, see G02BA.
Progestogens only used in neoplastic diseases, see L - Antineoplastic and immunomodulating agents.
The group is subdivided according to chemical structure.

The DDDs are based on gynecological indications, for instance corpus luteum insufficiency and endometriosis.

G03DB - Pregnadien Derivatives

G03DB03 - Medrogestone

2024	©ywesee GmbH